questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Monokines
Interleukine-1
Interleukine-1 bêta
Interleukine-1 bêta : Questions médicales fréquentes
Diagnostic
5
Interleukine-1 bêta
Cytokines
Tests de laboratoire
Interleukine-1 bêta
Inflammation
Analyse de sang
Interleukine-1 bêta
Symptômes
Fièvre
Interleukine-1 bêta
Arthrite
Goutte
Interleukine-1 bêta
Maladies auto-immunes
Inflammation
Symptômes
5
Interleukine-1 bêta
Symptômes
Inflammation
Interleukine-1 bêta
Douleur
Articulations
Interleukine-1 bêta
Inflammation
Signes cliniques
Interleukine-1 bêta
Fièvre
Réponse immunitaire
Interleukine-1 bêta
Symptômes neurologiques
Fatigue cognitive
Prévention
5
Interleukine-1 bêta
Prévention
Mode de vie sain
Interleukine-1 bêta
Vaccination
Réponse immunitaire
Interleukine-1 bêta
Stress
Inflammation
Interleukine-1 bêta
Alimentation
Antioxydants
Interleukine-1 bêta
Sommeil
Santé immunitaire
Traitements
5
Interleukine-1 bêta
Inhibiteurs
Anakinra
Interleukine-1 bêta
Arthrite
Médicaments anti-inflammatoires
Interleukine-1 bêta
Corticostéroïdes
Inflammation
Interleukine-1 bêta
Plantes médicinales
Anti-inflammatoires
Interleukine-1 bêta
Thérapie génique
Maladies inflammatoires
Complications
5
Interleukine-1 bêta
Complications
Maladies auto-immunes
Interleukine-1 bêta
Maladies cardiovasculaires
Inflammation
Interleukine-1 bêta
Diabète
Résistance à l'insuline
Interleukine-1 bêta
Infections
Système immunitaire
Interleukine-1 bêta
Cancer
Inflammation chronique
Facteurs de risque
5
Interleukine-1 bêta
Facteurs de risque
Obésité
Interleukine-1 bêta
Âge
Inflammation chronique
Interleukine-1 bêta
Mode de vie sédentaire
Inflammation
Interleukine-1 bêta
Maladies chroniques
Diabète
Interleukine-1 bêta
Régime alimentaire
Graisses saturées
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interleukine-1 bêta : Questions médicales les plus fréquentes",
"headline": "Interleukine-1 bêta : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interleukine-1 bêta : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-26",
"dateModified": "2026-03-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interleukine-1 bêta"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Interleukine-1",
"url": "https://questionsmedicales.fr/mesh/D007375",
"about": {
"@type": "MedicalCondition",
"name": "Interleukine-1",
"code": {
"@type": "MedicalCode",
"code": "D007375",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.500.400"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interleukine-1 bêta",
"alternateName": "Interleukin-1beta",
"code": {
"@type": "MedicalCode",
"code": "D053583",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "S Taurone",
"url": "https://questionsmedicales.fr/author/S%20Taurone",
"affiliation": {
"@type": "Organization",
"name": "Department of Sensory Organs, \"Sapienza\" University of Rome. t.samanta@yahoo.it."
}
},
{
"@type": "Person",
"name": "M T Santarelli",
"url": "https://questionsmedicales.fr/author/M%20T%20Santarelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Sensory Organs, \"Sapienza\" University of Rome."
}
},
{
"@type": "Person",
"name": "M Artico",
"url": "https://questionsmedicales.fr/author/M%20Artico",
"affiliation": {
"@type": "Organization",
"name": "Department of Sensory Organs, \"Sapienza\" University of Rome."
}
},
{
"@type": "Person",
"name": "Friederike Schulze",
"url": "https://questionsmedicales.fr/author/Friederike%20Schulze",
"affiliation": {
"@type": "Organization",
"name": "Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland. schulze.fritzi@gmail.com."
}
},
{
"@type": "Person",
"name": "Daniel T Meier",
"url": "https://questionsmedicales.fr/author/Daniel%20T%20Meier",
"affiliation": {
"@type": "Organization",
"name": "Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Electrochemical peptide-based biosensor for the detection of the inflammatory disease biomarker, interleukin-1beta.",
"datePublished": "2024-01-30",
"url": "https://questionsmedicales.fr/article/38355228",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aca.2024.342287"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder.",
"datePublished": "2024-06-26",
"url": "https://questionsmedicales.fr/article/38924009",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0306125"
}
},
{
"@type": "ScholarlyArticle",
"name": "Salivary interleukin-17A and interleukin-18 levels in patients with celiac disease and periodontitis.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38756445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.17374"
}
},
{
"@type": "ScholarlyArticle",
"name": "Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages.",
"datePublished": "2024-03-25",
"url": "https://questionsmedicales.fr/article/38527803",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26508/lsa.202302399"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37507547",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-39487-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Monokines",
"item": "https://questionsmedicales.fr/mesh/D015846"
},
{
"@type": "ListItem",
"position": 6,
"name": "Interleukine-1",
"item": "https://questionsmedicales.fr/mesh/D007375"
},
{
"@type": "ListItem",
"position": 7,
"name": "Interleukine-1 bêta",
"item": "https://questionsmedicales.fr/mesh/D053583"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interleukine-1 bêta - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interleukine-1 bêta",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interleukine-1 bêta",
"description": "Comment mesurer l'interleukine-1 bêta ?\nQuels tests diagnostiques sont utilisés ?\nQuels symptômes indiquent une élévation de l'IL-1β ?\nL'IL-1β est-elle liée à des maladies spécifiques ?\nComment l'IL-1β est-elle impliquée dans les maladies auto-immunes ?",
"url": "https://questionsmedicales.fr/mesh/D053583#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interleukine-1 bêta",
"description": "Quels sont les symptômes d'une surproduction d'IL-1β ?\nL'IL-1β peut-elle causer des douleurs articulaires ?\nY a-t-il des signes cliniques d'inflammation liés à l'IL-1β ?\nL'IL-1β est-elle liée à la fièvre ?\nQuels symptômes neurologiques peuvent être associés à l'IL-1β ?",
"url": "https://questionsmedicales.fr/mesh/D053583#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interleukine-1 bêta",
"description": "Peut-on prévenir l'élévation de l'IL-1β ?\nLes vaccinations influencent-elles l'IL-1β ?\nComment le stress affecte-t-il l'IL-1β ?\nL'alimentation peut-elle réduire l'IL-1β ?\nLe sommeil influence-t-il l'IL-1β ?",
"url": "https://questionsmedicales.fr/mesh/D053583#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interleukine-1 bêta",
"description": "Quels traitements ciblent l'IL-1β ?\nComment l'IL-1β est-elle traitée dans l'arthrite ?\nLes corticostéroïdes affectent-ils l'IL-1β ?\nY a-t-il des traitements naturels pour l'IL-1β ?\nComment la thérapie génique pourrait-elle cibler l'IL-1β ?",
"url": "https://questionsmedicales.fr/mesh/D053583#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interleukine-1 bêta",
"description": "Quelles complications peuvent survenir avec l'IL-1β élevée ?\nL'IL-1β est-elle liée à des maladies cardiovasculaires ?\nComment l'IL-1β affecte-t-elle le diabète ?\nY a-t-il des risques d'infections avec l'IL-1β élevée ?\nL'IL-1β est-elle impliquée dans le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D053583#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interleukine-1 bêta",
"description": "Quels facteurs augmentent l'IL-1β ?\nL'âge influence-t-il l'IL-1β ?\nLe mode de vie sédentaire affecte-t-il l'IL-1β ?\nLes maladies chroniques influencent-elles l'IL-1β ?\nLe régime alimentaire joue-t-il un rôle dans l'IL-1β ?",
"url": "https://questionsmedicales.fr/mesh/D053583#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer l'interleukine-1 bêta ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'interleukine-1 bêta peut être mesurée par des tests ELISA dans le sérum ou les fluides biologiques."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de liquide synovial peuvent être utilisés pour évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une élévation de l'IL-1β ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires et fatigue peuvent indiquer une élévation de l'IL-1β."
}
},
{
"@type": "Question",
"name": "L'IL-1β est-elle liée à des maladies spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-1β est associée à des maladies comme l'arthrite rhumatoïde et la goutte."
}
},
{
"@type": "Question",
"name": "Comment l'IL-1β est-elle impliquée dans les maladies auto-immunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-1β contribue à l'inflammation et à la destruction des tissus dans les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surproduction d'IL-1β ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs, fatigue et inflammation des articulations."
}
},
{
"@type": "Question",
"name": "L'IL-1β peut-elle causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-1β est impliquée dans la douleur et l'inflammation des articulations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques d'inflammation liés à l'IL-1β ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur sont des signes cliniques d'inflammation."
}
},
{
"@type": "Question",
"name": "L'IL-1β est-elle liée à la fièvre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-1β peut induire une réponse fébrile en stimulant le système immunitaire."
}
},
{
"@type": "Question",
"name": "Quels symptômes neurologiques peuvent être associés à l'IL-1β ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue cognitive et des troubles de l'humeur peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'élévation de l'IL-1β ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, avec une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles l'IL-1β ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent moduler la réponse immunitaire et l'IL-1β."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il l'IL-1β ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut augmenter l'expression de l'IL-1β et aggraver l'inflammation."
}
},
{
"@type": "Question",
"name": "L'alimentation peut-elle réduire l'IL-1β ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en antioxydants et oméga-3 peut aider à réduire l'IL-1β."
}
},
{
"@type": "Question",
"name": "Le sommeil influence-t-il l'IL-1β ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sommeil de qualité peut réguler l'expression de l'IL-1β et améliorer la santé immunitaire."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent l'IL-1β ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de l'IL-1β, comme l'anakinra, sont utilisés pour traiter certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment l'IL-1β est-elle traitée dans l'arthrite ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anti-inflammatoires et des inhibiteurs de l'IL-1β sont utilisés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils l'IL-1β ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression de l'IL-1β et l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour l'IL-1β ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes anti-inflammatoires peuvent aider à moduler l'IL-1β, mais des études sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique pourrait-elle cibler l'IL-1β ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique pourrait moduler l'expression de l'IL-1β pour traiter des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'IL-1β élevée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies auto-immunes, des infections et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "L'IL-1β est-elle liée à des maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-1β est impliquée dans l'inflammation qui peut contribuer aux maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment l'IL-1β affecte-t-elle le diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-1β peut contribuer à l'inflammation et à la résistance à l'insuline dans le diabète."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'infections avec l'IL-1β élevée ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une élévation de l'IL-1β peut affaiblir le système immunitaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "L'IL-1β est-elle impliquée dans le cancer ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-1β peut favoriser l'inflammation chronique, un facteur de risque pour certains cancers."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent l'IL-1β ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque d'élévation de l'IL-1β."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il l'IL-1β ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé est associé à une augmentation de l'IL-1β et à une inflammation chronique."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire affecte-t-il l'IL-1β ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à l'élévation de l'IL-1β et à l'inflammation."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles l'IL-1β ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète et l'arthrite peuvent augmenter les niveaux d'IL-1β."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire joue-t-il un rôle dans l'IL-1β ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en sucres et graisses saturées peut augmenter l'IL-1β."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/03/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Sensory Organs, "Sapienza" University of Rome. t.samanta@yahoo.it.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Department of Sensory Organs, "Sapienza" University of Rome.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Department of Sensory Organs, "Sapienza" University of Rome.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland. schulze.fritzi@gmail.com.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Clinic of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland and Department of Biomedicine, University of Basel, Basel, Switzerland.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, School of Health and Life Sciences, North South University, Bashundhara R/A, Dhaka 1229, Bangladesh.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, School of Health and Life Sciences, North South University, Bashundhara R/A, Dhaka 1229, Bangladesh. Electronic address: hasan.reza@northsouth.edu.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Molecular Physiology Division, Faculty of Science, Beni-Suef University, Salah Salim St., Beni Suef, 62511, Egypt. adel_men2020@yahoo.com.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, GO, Brazil.
Department of Internal Medicine and Radboud Center of Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, Netherlands.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Departments of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Departments of Pediatrics, College of Medicine, Najran University, Najran, Saudi Arabia.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Department of Family and Community Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Publications dans "Interleukine-1 bêta" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Zagazig University, Zagazig, Egypt.
Publications dans "Interleukine-1 bêta" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Nippon Medical School.
Publications dans "Interleukine-1 bêta" :
1 publication dans cette catégorie
Affiliations :
Department of Pediatrics, Nippon Medical School.
Publications dans "Interleukine-1 bêta" :
1 publication dans cette catégorie
Affiliations :
Laboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Sciences.
Publications dans "Interleukine-1 bêta" :
This paper reports the development of a highly sensitive and selective electrochemical peptide-based biosensor for the detection of the inflammatory disease biomarker, interleukin-1beta (IL-1β). To th...
Obsessive-compulsive disorder (OCD) is a highly prevalent neuropsychiatric disorder. Recently, there has been a growing interest in investigating the association between pro-inflammatory cytokines and...
This study recruited 58 OCD patients and 30 age-sex-matched healthy controls (HCs). A qualified psychiatrist diagnosed OCD patients and assessed HCs based on the Diagnostic and Statistical Manual for ...
The results showed that serum IL-1β levels were significantly elevated in OCD patients compared to HCs (23.68±1.65 pg/ml vs. 15.75±1.02 pg/ml; p = 0.002). Similarly, OCD patients exhibited significant...
These results suggest that serum IL-1β and IL-6 levels may be associated with the pathophysiology of OCD. Also, these cytokines levels in blood samples can serve as early risk assessment tools for the...
An increased level of interleukin-17A and interleukin-18 in the serum and intestinal mucosa of celiac disease patients reflecting the severity of villous atrophy and inflammation was documented. Thus,...
The study involved 23 participants with serologically confirmed celiac disease (CD) and 23 control subjects. The CD patients had been following a gluten-free diet (GFD) for a minimum of 1 year and had...
The periodontal findings indicated significantly lower values in celiac disease patients adhering to a gluten-free diet compared to control subjects (...
Celiac disease patients on gluten-free diet exhibited better periodontal health compared to control subjects. However, increased levels of salivary IL-17A, IL-18 and IL-1B levels were associated with ...
Inflammasomes are immune complexes whose activation leads to the release of pro-inflammatory cytokines IL-18 and IL-1β. Type I IFNs play a role in fighting infection and stimulate the expression of IF...
Intrahepatic cholangiocarcinoma (iCCA) is a rare, understudied primary hepatic malignancy with dismal outcomes. Aiming to identify prognostically relevant single-nucleotide polymorphisms, we analyzed ...
There is increasing evidence that immune dysfunction plays an important role in the pathogenesis of schizophrenia. Meso Scale Discovery (MSD) is bioanalytical method, which can detect serum inflammato...
We recruited 116 participants, including patients with first-episode schizophrenia (FEG, n = 40), recurrence patients (REG, n = 40) with relapse-episode schizophrenia, and a control group (healthy peo...
There were significant differences in serum IL-1β (F = 2.37, P = 0.014) and IL-16 (F = 4.40, P < 0.001) levels among the three groups. The level of serum IL-1β in the first-episode group was significa...
Serum IL-1β and IL-16 levels were different between patients with schizophrenia and healthy people. Serum IL-1β levels in first-episode schizophrenia and serum IL-16 levels in relapsing schizophrenia ...
Females represent a majority of chronic pain patients and show greater inflammatory immune responses in human chronic pain patient populations as well as in animal models of neuropathic pain. Recent d...
We previously reported that patients with multidrug-resistant tuberculosis (MDR-TB) showed low systemic and Mtb-induced Th22 responses associated to high sputum bacillary load and severe lung lesions ...
IL-37 is an anti-inflammatory cytokine involved in inflammatory and autoimmune diseases. We aimed to investigate the association between IL-37 genetic variants, IL-37 plasma levels, and various clinic...
The study included a control group with no history of primary hyperuricemia/gout, (n = 50), asymptomatic hyperuricemia (n = 74), intercritical gout (n = 200), acute gouty flare (n = 18), and chronic t...
Plasma levels of IL-37 were significantly higher in asymptomatic hyperuricemic (p = 0.045), intercritical gout (p = 0.001), and chronic tophaceous gout (p = 0.021) cohorts when compared to control gro...
We demonstrated the up-regulation of IL-37 levels across the clinical phases of gout: asymptomatic hyperuricemia, intercritical, and chronic tophaceous gout compared to control. Moreover, 15 genetic v...
Obesity increases tendinopathy's risk, but its mechanisms remain unclear. This study examined the effect of high-fat diet (HFD)-induced obesity on the outcomes and inflammation of collagenase-induced ...
Mice were fed with standard chow (SC) or HFD for 12 weeks. Bacterial collagenase I or saline was injected over the patellar tendons of each mouse. At weeks 2 and 8 post-injection, the patellar tendons...
HFD aggravated CI tendon injury with an increase in vascularity and cellularity compared to SC treatment. The histopathological score (week 2:...
HFD-induced obesity exacerbated histopathological, functional, and biomechanical changes in the CI tendon injury model, which was associated with an upregulation of IL-1β and MMP-1....